Medpace Holdings, Inc.MEDPNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+19.9%
5Y CAGR+22.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+19.9%/yr
vs +20.4%/yr prior
5Y CAGR
+22.3%/yr
Consistent
Acceleration
-0.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.77B | +21.8% |
| 2024 | $1.45B | +6.7% |
| 2023 | $1.36B | +32.5% |
| 2022 | $1.03B | +26.2% |
| 2021 | $814.22M | +25.8% |
| 2020 | $647.20M | +5.2% |
| 2019 | $615.27M | +25.8% |
| 2018 | $489.06M | +87.0% |
| 2017 | $261.46M | +4.8% |
| 2016 | $249.47M | - |